|Articles|April 5, 2022
Qwince Joins AiCure Parntership Program
New partnership brings AiCure solutions to Italy.
Advertisement
Through its CRO partnership program, AiCure Partners for Excellence (AiPEX), AiCure is partnering with Qwince. Leveraging Qwince's consulting experience in data science, pharmaceuticals, and technology, the partnership will aim to foster clinical and commercial opportunities for the deployment of AiCure's AI platform with pharmaceutical sponsors and government healthcare departments.
Read more about this new partnership
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Life Sciences Can’t Afford Fragmented Data and Disconnected Teams
2
ACT Brief: Patient Preferences in Remote Trials, Sanofi’s Neurology and Immunology Deals, and AI-Driven Biomarkers in Oncology
3
FDA Approves GSK’s Exdensur for Severe Asthma Based on SWIFT Phase III Data
4
What Patients Want from Remote Trials: New Survey Data Reveals Preferences Around Usability, Trust, and Participation
5